AU1289695A - Human stanniocalcin-alpha - Google Patents

Human stanniocalcin-alpha

Info

Publication number
AU1289695A
AU1289695A AU12896/95A AU1289695A AU1289695A AU 1289695 A AU1289695 A AU 1289695A AU 12896/95 A AU12896/95 A AU 12896/95A AU 1289695 A AU1289695 A AU 1289695A AU 1289695 A AU1289695 A AU 1289695A
Authority
AU
Australia
Prior art keywords
alpha
human stanniocalcin
stanniocalcin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12896/95A
Other versions
AU687962B2 (en
Inventor
Robert D Fleischmann
Henrik Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU1289695A publication Critical patent/AU1289695A/en
Application granted granted Critical
Publication of AU687962B2 publication Critical patent/AU687962B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
AU12896/95A 1994-11-10 1994-11-10 Human stanniocalcin-alpha Ceased AU687962B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/013206 WO1996015147A1 (en) 1994-11-10 1994-11-10 Human stanniocalcin-alpha

Publications (2)

Publication Number Publication Date
AU1289695A true AU1289695A (en) 1996-06-06
AU687962B2 AU687962B2 (en) 1998-03-05

Family

ID=22243284

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12896/95A Ceased AU687962B2 (en) 1994-11-10 1994-11-10 Human stanniocalcin-alpha

Country Status (6)

Country Link
EP (1) EP0797592A4 (en)
JP (1) JPH10509036A (en)
KR (1) KR100432260B1 (en)
AU (1) AU687962B2 (en)
NZ (1) NZ277605A (en)
WO (1) WO1996015147A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008322A (en) * 1996-04-02 1999-12-28 Zymogenetics, Inc. Stanniocalcin-2
US6538119B2 (en) * 1997-11-18 2003-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
ATE363534T1 (en) * 1998-04-10 2007-06-15 Daiichi Seiyaku Co HUMAN STANNIOCALCIN AND ITS USE FOR INHIBITING ADIPOGENesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003949A1 (en) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology The cs protein of the corpuscles of stannius
US5837498A (en) * 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin

Also Published As

Publication number Publication date
WO1996015147A1 (en) 1996-05-23
AU687962B2 (en) 1998-03-05
JPH10509036A (en) 1998-09-08
EP0797592A1 (en) 1997-10-01
KR100432260B1 (en) 2004-09-16
KR970707155A (en) 1997-12-01
NZ277605A (en) 1999-03-29
EP0797592A4 (en) 1999-10-20

Similar Documents

Publication Publication Date Title
AU3075895A (en) Endoscope
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU3304995A (en) 2-Hydroxyphenyltriazines
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4131596A (en) Polyglycomers
AU4044795A (en) Handleset
AU3322795A (en) Endoscope
AU2308295A (en) Heterocyclylbenzonitriles
AU1963395A (en) Boom-structure
AU4029295A (en) Thienopyridones
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU7470494A (en) Human oxalyl-coa decarboxylase
AU7469594A (en) Poop-scoop
AU3166195A (en) Acylimidazopyridines
AU1645599A (en) Human matrilin-3
AU8155898A (en) Human preprotachykinin b
AU4590996A (en) Boekomslag
AU1289695A (en) Human stanniocalcin-alpha
AU6782894A (en) Human dnase
AU3166095A (en) Benzylimidazopyridines
AU1255895A (en) Human mutt2
AU1603595A (en) Meso-azanoradamantanes
AU3446995A (en) Biodestumping
AU3417395A (en) Hydro-ethano-indeno-pyridines